HNGE insider files Form 144 to sell 15,000 shares on NYSE

HNGE filed a notice that an affiliated holder plans to sell common stock under Rule 144.

Rhea-AI Filing Summary

HNGE filed a notice that an affiliated holder plans to sell common stock under Rule 144. The filing covers 15,000 shares of common stock with an aggregate market value of $680,400.00, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. The filing notes that there were 37,919,155 shares or other units outstanding at the time of the notice.

The shares to be sold were acquired as performance stock units from the issuer on 04/01/2023, with 15,000 securities acquired on that date and the payment nature listed as "N/A." The seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HNGE Form 144 filing report?

The Form 144 reports a proposed sale of 15,000 shares of HNGE common stock with an aggregate market value of $680,400.00 under Rule 144.

Who is handling the sale of HNGE shares in this Form 144?

The sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which exchange will the HNGE shares be sold and when?

The filing lists the NYSE as the securities exchange and states an approximate date of sale of 11/21/2025.

How many HNGE shares were outstanding at the time of the Form 144 notice?

The notice states that 37,919,155 shares or other units of HNGE were outstanding at the time of the filing.

How and when were the HNGE shares being sold acquired?

The 15,000 HNGE common shares were acquired on 04/01/2023 as performance stock units from the issuer, with the nature of payment described as "N/A."

What representation does the selling person make in the HNGE Form 144?

By signing the notice, the selling person represents that they do not know any material adverse information about HNGE’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/21/2025 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783108
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES PURSLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15000	680400.00	37919155	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2023	Performance Stock Units	Issuer			15000	04/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of performance stock units during the period of 04/1/2023 through 03/31/2025.
Date of Notice	11/21/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Pursley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)